ALBANY, New York, March 29, 2017 - MarketResearchReports.biz has announced the addition of a report, titled “Global HPV Testing Market 2016-2020”. The in-depth research study on the global human papilloma virus (HPV) testing market provides insights into the current market dynamics, prevailing trends, opportunities, market share and size of key product segments, and competitive landscape. The research study analyzes the major factors influencing the uptake of HPV testing across various demographics. Technological innovations in diagnostic kits and changes in reimbursement scenario expected to shape the competitive dynamics are analyzed. In addition, advancements in diagnostic technologies that are anticipated to boost the adoption among women in major regions are covered in the report.
Driven by a steady use of HPV testing kits in various regions, the global HPV testing market is poised to expand at an impressive CAGR of 16.17% during 2016 – 2020. The increased adoption of these tests in conjunction with a Pap test as a preventive measure to screen early cervical cancers or pre-cancers caused by HPV among women within the age of 30 has fuelled the market.
The HPV testing market is majorly driven by various government programs focused on the detection of HPV, growing awareness of high-risk genital HPV, prevalence of cervical cancer among women, and favorable reimbursement policies. Technological advances in diagnosis have made the testing convenient and easy. For instance, technology enables women to undertake the HPV test within the confines of home for detecting cervical cancer. The adoption of the safe, non-invasive, accurate, and efficient diagnostic test has spurred its demand in various parts of Sub-Saharan Africa.
For Sample Copy, click here: http://www.marketresearchreports.biz/sample/sample/902752
North America and Europe markets are expected to witness substantial demand for HPV testing. The impressive growth in the regional market is attributed to favorable initiatives adopted governments in several countries such as Canada, the U.S., and Brazil intensively initiating programs to screen cervical cancer and favorable reimbursement policies in these countries. Various clinical guidelines that facilitate early detection of cervical cancer is also expected to fuel the market’s growth.
However, low awareness in countries such as the UK, Finland, and France for the availability screening programs has led to lower market penetration. However, the preference of alternative diagnostic test such as Pap test for cervical cancer screening and limited awareness of non-invasive test in less developed regions are likely to hinder the market growth to an extent. In addition, lack of adequate number of health clinics in developing nations, coupled with lack of organized reimbursement policies, has hampered its uptake. On the other hand, intensive government efforts to combat the deaths caused due to cervical cancer has led to the inclusion of the HPV testing is in various cervical cancer screening programs in regions such as the U.S., the U.K., South Africa, and China, boosting the global market.
Major players operating in this market include BD, Abbott Laboratories, Roche Diagnostics, and Qiagen.
To order report Call Toll Free: 866-997-4948 or send an email on firstname.lastname@example.org